Medically reviewed on December 15, 2017.
Applies to the following strengths: 250 mcg/0.5 mL
Usual Adult Dose for:
Usual Adult Dose for Gonadotropin Inhibition
To prevent leuteinizing hormone (LH) surges during controlled ovarian hyperstimulation:
0.25 mg subcutaneously once a day. Ganirelix is most conveniently administered in the abdomen around the navel or upper thigh. Generally, exogenous follicle stimulating hormone (FSH) is initiated on day 2 or 3 of a natural menstrual cycle. Ganirelix is administered beginning day 7 or 8 (day 6 of FSH treatment). Ganirelix therapy is continued until adequate follicular maturation is noted, at which time human chorionic gonadotropin (hGC) is administered.
More about ganirelix
- Ganirelix Side Effects
- During Pregnancy
- Drug Interactions
- Drug class: gonadotropin-releasing hormone antagonists
Other brands: Antagon